Rapport Therapeutics Statistics
NASDAQ: RAPPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
23.16-0.43 (-1.82%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Rapport Therapeutics by the numbers
Rapport Therapeutics has a market capitalization of $1.37 billion based on 59.28M shares outstanding. With trailing EPS of $-3.17, Rapport Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.4% below its 50-day average and 34.8% below its 200-day average.
Average daily trading volume is 790.62K shares, or about $18.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RAPP valuation vs. peer median
| Metric | RAPP | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.37B | $1.41B | -3% |
| Avg. volume | 790.62K | 965.94K | -18% |
Peer median across 8 companies: NRIX, TYRA, ANAB, ADRX, SRPT, KLRA, DMRA, QURE.
Valuation
- Market cap
- $1.37B
- EPS (TTM)
- $-3.17
- Shares outstanding
- 59.28M
Price and trading
- Previous close
- 23.59
- Open
- 23.23
- Day range
- 23.00 – 23.83
- 52-week range
- 22.06 – 52.93
- 52-week change
- -15.01%
- Beta
- —
- Volume
- 437.72K
- Average volume
- 790.62K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 1.37B
- Forward Pe
- -5.84
- Eps
- -3.17
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 52.93
- Week52 Low
- 22.06
- Avg Volume
- 790.62K
- Shares Outstanding
- 59.28M
- Ma50
- 29.85
- Ma200
- 35.51
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -56.24%
- Pct From52w Low
- 4.98%